Login to Your Account

Clinic roundup

Friday, January 10, 2014
Altheus Therapeutics Inc., of Oklahoma City, said it completed enrollment for ZA201, a six-week, double-blind, active-controlled Phase II trial of the efficacy and safety of Zoenasa rectal gel in approximately 120 adult patients with left-sided, or distal, ulcerative colitis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription